$1.7 billion in cash. That is where Brink’s ended the three months ended June 30, up 20.4% from a year earlier.
The surface reading is simple: more money in the bank, more revenue coming through the armored-truck doors, and diluted EPS up 3.9% to $1.07. The less tidy part is that operating income barely moved, slipping to $133.3 million from $133.9 million. Operating margin fell to 9.6% from 10.3%.
Brink’s added $100 million of revenue, but kept almost none of the operating profit attached to it. Net income still rose slightly, while diluted shares declined 2.1%, helping EPS. The latest three-month period puts the pressure point before the bottom line: the business grew, and the operating layer did not.
Management attributes the revenue increase to a combination of inflation-based price increases and organic growth in its AMS and DRS businesses, along with BGS revenue. Organic revenue growth was 4%, below the 7.1% reported increase after currency effects and other differences.
"Revenues increased 4% on an organic basis primarily due to inflation-based price increases, and organic growth in AMS and DRS revenue, as well as BGS revenue."
Brink's, Form 10-Q, Aug. 5, 2026
That makes the source of growth fairly legible: pricing did some of the work, with operating activity in two businesses supplying the rest. It does not, by itself, explain why the additional sales failed to produce additional operating income.
The cost line supplies the filing's strongest complication. Cost of revenues increased 5% to $1.0262 billion, which Brink’s attributed primarily to currency exchange rates and higher revenue. That increase was slower than reported revenue, but not enough to prevent the operating margin from contracting.
The cash jump also needs a narrower reading. Brink’s said the increase was mostly tied to lower capital spending, with cash paid for capital expenditures falling to $74.9 million from $110.7 million. Lower capex can lift cash in the period, but the company's free-cash-flow margin still declined 1.6 percentage points to negative 0.4%.
There is a second balance-sheet detail in the same direction of greater scale: accounts receivable rose 6.7%, broadly in line with reported revenue growth. Brink’s does not say why. The number is an observation, not a verdict on collections or demand.
The backdrop is a company that entered this report with a stronger annual operating margin than it had a year earlier, at 11.1% in 2025 versus 9.0% in 2024. The latest filing does not extend that improvement cleanly into the current period. Revenue growth is present, but its conversion into operating profit is the unresolved piece.
At the latest close, Brink’s shares were $118.19, up 2.2% on Aug. 4. That price move is a market fact, not an explanation for the filing's arithmetic. The more useful question is operational: in Brink’s next quarterly report, does the 9.6% margin move back toward the prior-year level while cash generation is reported alongside the lower capex base, or does the company leave the revenue-to-profit gap in place?
Source: Brink's Form 10-Q filed Aug. 5, 2026, for the three months ended June 30, 2026.